No Result
View All Result
  • Login
  • Register
Business & Technology
SUBSCRIBE
  • .
  • Thought Leadership
  • Conversations
  • International Voices
  • News
  • Wealth
  • Digital Transformation
  • Lifestyle
  • Videos
  • Podcasts
  • .
  • Thought Leadership
  • Conversations
  • International Voices
  • News
  • Wealth
  • Digital Transformation
  • Lifestyle
  • Videos
  • Podcasts
No Result
View All Result
Biztech Asia
Home News

Developing countries get first priority to China’s Covid vaccines: Why?

by editorial
10/12/20
in News
2 min read
0
Developing countries get first priority to China’s Covid vaccines: Why?

As the vaccine race heats up, China has promised countries like Malaysia and the Philippines to a number of African countries first priority to Beijing’s home-grown vaccines when are ready to be distributed. Experts said it is a move that’s raised questions about China’s intent and could put pressure on some of these countries to support Beijing’s commercial and political interests.

Chinese companies have also signed agreements with some of these developing nations to test and manufacture the vaccines.

According to Imogen Page-Jarrett of The Economist Intelligence Unit, she doesn’t think it’s completely altruistic, thinks they are seeking some benefits from this. China wants to expand its commercial and also strategic interests in these countries. The vaccines may be “a means to expand China’s influence and soft power” as well as ease frictions with countries that may blame China for the pandemic.

For its part, China has said it “will not turn Covid-19 vaccines into any kind of geopolitical weapon or diplomatic tool, and it opposes any politicization of vaccine development,” according to an editorial by state news agency Xinhua.

Also according to Chong Ja Ian, an associate professor of political science at the National University of Singapore, China could demand cooperation on a “whole range” of issues. They include practical discussions such as the code of conduct in the contested South China Sea, as well as gaining more acceptance of Chinese technology products. There’s so much overlap of Chinese interests with the concerns of other countries and so many areas where China might want to get ahead, especially with the US.

Whether China is able to gain political advantage from its vaccines depends on the safety of its candidates and the affordability of alternatives, experts said.

Data from China has been less readily available, although pharmaceutical companies in the US and Europe have largely been forthcoming with results from their trials.

But the EIU’s Page-Jarrett said there’s reason to trust China’s vaccines. On the assumption that it needs to vaccinate its own population before others, then it’s really not going to go ahead with any vaccine that it does not believe is safe.

Also according to Mardell from the Mercator Institute for China Studies, the high efficacy vaccines developed in the West have been oversubscribed and “snapped up by a handful of very rich countries which may mean there’s room for China’s vaccines, especially in developing countries that cannot afford expensive options produced by Pfizer-BioNTech or Moderna.

Those vaccines are developed using new messenger RNA technology — a new approach to vaccines that uses genetic material to trigger an immune response. Such vaccines need to be stored at extremely low temperatures.

The research analyst, Page-Jarrett, said most countries have signed purchase agreements with multiple vaccine providers because “no one wants to put their eggs in one basket.

Previous Post

Four in five FinTech firms in ASEAN set on expansion despite pandemic

Next Post

Retirement Planning 101 – What are the basics you need to start financial planning for retirement

editorial

editorial

Related Posts

MDEC appoints new chief financial officer
News

MDEC appoints new chief financial officer

M&A valuations boom in the second half of 2020 despite impacts of the pandemic
News

M&A valuations boom in the second half of 2020 despite impacts of the pandemic

Greater China equities – a resilient way forward
News

Growing foreign interest pours into China

News

Biden’s inauguration in focus; markets off to a sluggish start

Tesla delivers its first China-produced Model Y crossovers
News

Tesla delivers its first China-produced Model Y crossovers

Greater China equities – a resilient way forward
News

China beats economists’ forecast – economy grows 2.3% in 2020

Next Post
Retirement Planning 101 – What are the basics you need to start financial planning for retirement

Retirement Planning 101 - What are the basics you need to start financial planning for retirement

Sector rotation from tech stocks to value and cyclicals

Global Recovery Story is intact

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

I agree to the Terms & Conditions and Privacy Policy.

Recommended Stories

Asia to lead the rebound once bubble resumes

Asia to lead the rebound once bubble resumes

The Macallan Red Collection takes off with a flying start

The Macallan Red Collection takes off with a flying start

China’s exports surge by 21.1% on strong global demand

China’s exports surge by 21.1% on strong global demand

Popular Stories

  • Economic recovery: an elusive thought?

    Economic recovery: an elusive thought?

    0 shares
    Share 0 Tweet 0
  • Cannibalising your business can be profitable

    0 shares
    Share 0 Tweet 0
  • Sexual fulfillment builds confidence and well-being

    0 shares
    Share 0 Tweet 0
  • Tech Stocks – Ant gets stomped on but REITS offer stability amid volatility

    0 shares
    Share 0 Tweet 0
  • Singapore REITS and China tech stocks – Which should you buy?

    0 shares
    Share 0 Tweet 0

About Us

A Business and Technology digital publication that engages business leaders in business and technology conversations to help everyone pivot, adapt, and thrive in these turbulent times.

LEARN MORE »

Contact Us

Phone: 016-2011 050

Email: editor@biztech.asia

Address:
Level 18, Boutique Office 1 (B01-C)
Menara 2, No. 3, Jalan Bangsar,
KL Eco City, 59200, Kuala Lumpur.

Email Newsletter

Loading

© 2020 Business & Technology - made possible by Milestones Digital.

No Result
View All Result
  • Home
  • Thought Leadership
  • Conversations
  • International Voices
  • News
  • Wealth
  • Digital Transformation
  • Lifestyle
  • Videos
  • Podcasts
  • Login
  • Sign Up

© 2020 Business & Technology - made possible by Milestones Digital.

Welcome Back!

Sign In with Facebook
Sign In with Google
OR

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Sign Up with Facebook
Sign Up with Google
OR

Fill the forms bellow to register

*By registering into our website, you agree to the Terms & Conditions and Privacy Policy.
All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In
This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.
Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

will use the information you provide on this form to be in touch with you and to provide updates and marketing.